Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x100px

Organisation › Details

TreeFrog Therapeutics SAS

https://www.treefrog.fr

TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-StemTM technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 80 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M over the past 3 years to advance its pipeline of stem cell-based therapies in the field of neurodegeneration, cardio-metabolic disorders, and immuno-oncology. The company is currently opening technological hubs in Boston, USA, and Kobe, Japan, to drive the adoption of C-StemTM and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy. Since 2018, TreeFrog Therapeutics has been actively participating to the Japanese Society for Regenerative Medicine and the Link-J consortium, and is a Supporting Member of the CiRA Foundation. In 2020, TreeFrog Therapeutics launched a collaboration on iPSC quality with the Foundation for Biomedical Research and Innovation at Kobe (FBRI) and the Harvard Stem Cell Institute, which was awarded by the prestigious Prix Galien MedStartup Prize in New York. *

	Start	2018-12-07 established
	Group	TreeFrog Therapeutics (Group)
	Industry	C-Stem™ technology platform (based on 3D stem cell culture)
	Industry 2	stem cell therapy
	Person	Desdouits, Frédéric (TreeFrog Therapeutics 202109– CEO before PCAS + Seqens + Pierre Fabre + Bionest Partners)
	Person 2	Alessandri, Kévin (TreeFrog Therapeutics 202201– Managing Director TreeFrog Tx Inc before CEO + CTO + Co-Founder)

	Region	Bordeaux
	Country	France
	Street	30 avenue Gustave Eiffel Bât A
	City	33600 Pessac (Bordeaux)
	Tel	+33-7-6259-7498
		Address record changed: 2024-01-05

Basic data	Employees	B: 11 to 50 (2021-09-13)

		* Document for »About Section«: TreeFrog Therapeutics SAS. (4/8/22). "Press Release: TreeFrog Therapeutics Opens Technological Hub in Kobe, Japan, to Drive Partnerships Opportunities in the Field of iPSC-derived Cell Therapies". Kobe.

		Record changed: 2024-03-30

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for TreeFrog Therapeutics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)